Infect Chemother. 2010 Aug;42(4):216-222. English.
Published online Aug 30, 2010.
Copyright © 2010 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
Original Article

Interventions to Prevent Catheter-Associated Blood-stream Infections: A Multicenter Study in Korea

Sunmi Yoo,1 Sook-In Jung,2,3 Gwang-Sook Kim,2 Duck-Sun Lim,2 Jang-Wook Sohn,4,5 Jeong-Yeon Kim,4 Ji-Eun Kim,6,7 Yoon-Suk Jang,6 Sunju Jung,6 and Hyunjoo Pai6,7
    • 1Department of Family Medicine, Inje University Haeundae Paik Hospital, Busan, Korea.
    • 2Office of Hospital Infection Control, Chonnam National University, Gwangju, Korea.
    • 3Department of Internal Medicine, Chonnam National University, Gwangju, Korea.
    • 4Office of Hospital Infection Control, Korea University Anam Hospital, Seoul, Korea.
    • 5Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
    • 6Office of Hospital Infection Control, Hanyang University Seoul Hospital, Seoul, Korea.
    • 7Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea.
Received December 15, 2009; Revised April 07, 2010; Accepted May 05, 2010.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The purpose of this study was to determine the efficacy of infection-control interventions to decrease the incidence of catheter-associated bloodstream infections (CA-BSI) and to examine the sustainability of its effect during and after the intervention in Korea.

Materials and Methods

We conducted a prospective multi-strategy intervention in intensive care units (ICUs) at 3 university hospitals in Korea. The intervention consisted of education and on-site training for medical personnel involved in catheter care, active surveillance, and reinforcement of current intervention in each unit. After the intervention of 3 months, we identified CA-BSI cases of each hospital using the electronic database for 6 months.

Results

During the intervention, the number of CA-BSI decreased significantly compared to pre-interventional period (8.7 vs. 2.3 per 1,000 catheter days; rate ratio 0.28; 95% CI, 0.13-0.61). After the intervention, CA-BSI rate increased slightly, but was still significantly lower than that of pre-interventional period (4.3 per 1,000 catheter days; rate ratio, 0.49; 95% CI, 0.31-0.78). Reduction of gram-negative bacterial infections was noted during and after the intervention.

Conclusions

A multi-strategy approach to reduce CA-BSI could be implemented in diverse settings of medical and surgical units in Korea and decreased CA-BSI rates during the intervention.

Keywords
Catheter-associated bloodstream infections; Healthcare associated infection; Intensive care unit; Intervention

Introduction

Primary bloodstream infections are a frequent cause of morbidity and mortality in critically ill patients. According to the report from the National Healthcare Safety Network (NHSN) of the U.S. Centers for Disease Control and Prevention (CDC), catheter-associated bloodstream infections (CA-BSI) occur at a mean rate of 2.9 per 1000 catheter-days for medical intensive care units (ICUs) in American hospitals [1]. Mortality attributable to CA-BSI has been estimated to be as high as 35%, and the length of hospital stay is increased among infected patients [2-6]. In Korea, primary bloodstream infection was the third common nosocomial infection (24%) and CA-BSI occurred at a rate of 2.58 per 1000 catheter-days in 2006 [7]. However, CA-BSI rate varied among institutions: 10 percentile 0, 90 percentile 8.38/1000 catheter days in hospitals with more than 900 beds [7]. Therefore, interventions aimed to decrease the infection rate are necessary to reduce serious public health consequences of this nosocomial infection.

Prior studies from a single hospital have shown reductions in the rates of CA-BSI by various interventional efforts, including education and surveillance [8-14]. Recent multicenter studies also showed successful sustained reductions in the rates of infection [15, 16]. However, CA-BSI rate is still high in developing countries, and their efforts to reduce CA-BSI rate have scarcely been reported [17]. In Korea, there are some reports on the interventions that was employed to reduce CA-BSI [14, 18, 19] but all have been done in a single center setting and no report on multicenter trial exist.

Therefore, we initiated a prospective multicenter study to implement a multifaceted, education-based intervention in ICUs at 3 academic medical centers in Korea. The primary purpose of this study was to assess the effect of intervention and to examine the sustainability of its effect on lowering the incidence of bloodstream infection which was associated with central venous catheters during and after the intervention.

Materials and Methods

1. Study site

The study was conducted in 6 ICUs at 3 academic tertiary care hospitals (mean size, 950.3 beds; range, 893-1,014 beds) participating in the Korean Nosocomial Infection Surveillance System (KONIS) Prevention Program. Two hospitals are located in Seoul and one is located in Gwangju city (Table 1).

Table 1
Characteristics of Hospitals which Implemented Bloodstream Infection Prevention

2. Description of intervention

The program was a multi-strategy approach consisting of education and on-site training for medical personnel involved in catheter care, active surveillance by infection control practitioners, and reinforcement of current intervention program in each unit over a 3-month period. The study on intervention targeted healthcare providers' use of evidence-based procedures, recommended by the U.S. CDC and identified as having the greatest impact on the rate of catheter-related bloodstream infections [20]. The recommended strategies are education and training of healthcare providers who insert and maintain catheters, hand washing, using maximal sterile barrier precautions during catheter insertion, use of a 2% chlorhexidine preparation for skin antisepsis, avoiding the femoral site if possible, and removing unnecessary catheters. It was implemented by infection control teams to reinforce correct practices for central venous catheter (CVC) insertion, manipulation, and care for 3 months.

Education sessions and small-group meetings of staffs with or without two-weeks-campaign for appropriate hand-washing were carried out in three hospitals. The education included the principles concerning catheter care as follows: skin preparation, preferred site of CVC insertion, CVC insertion technique, the use of maximum barrier precaution, the use of antimicrobial impregnated CVC, dressing type, dressing interval, manipulation of hub and line, and CVC replacement. Small group education sessions were held with residents from medical and surgical departments who would potentially insert the CVC. Seperate education classes included nurses who worked in each ICU.

Observation and on-site training of CVC care were performed by infection control staffs and nurses in ICUs in each hospital. Two kinds of checklists were used: one for the insertion of CVCs, and the other for the maintenance of CVC in ICUs. The checklist for CVC insertion included hand-washing before procedure, skin preparation, site of insertion, use of maximum barrier precaution, and replacement. The other checklist for CVC dressing and manipulation was used once the patients with CVC had been admitted to ICUs or a CVC was inserted to patients in the ICUs. On-site training was performed during surveillance. When wrongdoing of catheter care was noticed, immediate correction was implemented. If central catheter was judged to be unnecessary, catheter removal was recommended.

3. Data collection

Baseline data collection to identify ICU-acquired, catheter-associated bloodstream infections was initiated in July 2007, 3 months before the intervention. All patients with CVC for more than 24 hours and admitted to ICUs were directly enrolled during both baseline and intervention periods. Study personnel collected the data on the total number of patient-days and the total number of catheter-days per month per ICU. Additional information obtained included patients' demographics, anatomic location of catheters (i.e., in the femoral, subclavian, or internal jugular veins), date and place of catheter insertion (i.e., in the ICU, operating room, emergency room, general ward, or other hospitals), and survival of patients. Each hospital's infection control team reviewed the results of all blood cultures that were carried out in the study units or within 48 hours after discharge from the unit. After the intervention, we monthly identified patient-days, catheter-days, CA-BSI cases, and their microbiological characteristics of each hospital from the KONIS electronic database from January to June 2008.

All of the data were presented on the basis of time when the intervention was implemented: at baseline (3 months), during the intervention (3 months), or after the intervention (6 months). A bloodstream infection was considered to be ICU-related if it occurred 48 hours after admission to or within 48 hours after discharge from the ICUs. We adopted the definitions of laboratory-confirmed CA-BSI, proposed by the CDC [21]. Laboratory-confirmed CA-BSI was defined as the detection of a pathogen isolated from one or more blood cultures and not related to other site infections.

4. Statistical analysis

The incidence rate of CA-BSIs per 1,000 catheter-days was calculated for each hospital and in aggregate. Comparisons of the incidence rates of CA-BSIs during and after the intervention with that of the baseline were analyzed by Poisson regression and 95% confidence intervals (CIs) were also presented. A multivariate logistic regression analysis was performed to estimate the simultaneous effects of multiple variables on the CA-BSI with the data directly collected during baseline and the intervention periods.

All data were analyzed using SPSS for Windows software (version 13.0; SPSS Inc, Chicago, IL, USA). P<0.05 was considered statistically significant.

Results

1. Baseline characteristics

The six study units had a mean of 18.5 ICU beds (range, 14-23 beds). We evaluated a total of 15,532 catheter-days (3,898 at baseline, 3,063 during the intervention, and 8,571 after the intervention) during 33,364 patient-days (7,943 at baseline, 8,319 during the intervention, and 18,568 after the intervention). The overall proportion of catheter-days to patient-days was not different significantly among 3 periods: 0.49, 0.45, and 0.46 catheter-days per patient-days, respectively.

2. CA-BSI rates and causative organisms

Thirty-four primary bloodstream infections occurred in 3,898 catheter-days at baseline, i.e. during 3 months before the intervention (Table 2). During the intervention period when education and active surveillance were implemented, the number of CA-BSI dropped to 7 in 3,063 catheter-days (8.7 vs. 2.3 per 1,000 catheter days; rate ratio, 0.28; 95% CI=0.13-0.61). After the intervention, the number of CA-BSI slightly increased to 37 in 8,571 catheter-days (4.3 per 1,000 catheter days; rate ratio, 0.49; 95% CI=0.31-0.78). This CA-BSI rate was still significantly lower than that of baseline. However, in the subgroup analysis, CA-BSI rates in each center, except for the center C, did not differ significantly during and after the intervention compared with that of baseline (Table 2).

Table 2
Catheter-associated Bloodstream Infection Rates and Incidence Rate-Ratios According to the Period of Implementation of the Intervention

Table 3 shows that the most common pathogens identified at baseline were Candida species, followed by Staphylococcus aureus and coagulase-negative staphylococci. During the intervention period, the number of isolates decreased from 36 to 7, with a decrease in the percentage of gram-negative bacterial isolates and a relative increase of gram-positive bacterial isolates. This phenomenon persisted until the period after the intervention, except for the increase of CA-BSI by Acinetobacter species.

Table 3
Microorganisms Isolated from Catheter-Associated Bloodstream Infection Cases during the Study Periods

3. Effect of the intervention on CA-BSI rates

In the univariate analysis, CA-BSI occurred more frequently in patients who were older, whose duration of admission in the ICU or hospital was longer, whose duration of catheter placement was longer, and to whom catheter was inserted in the ICU (data not shown). Therefore, multiple logistic regression analysis was performed to confirm the effect of the intervention after adjusting for these risk factors. Table 4 indicates that intervention (OR=0.395, 95% CI=0.167-0.938) significantly reduced the CA-BSI rate after adjusting for centers, patients' age, duration of catheter placement, and sites of catheter insertion. Old age of patients and longer duration of hospital admission were significant risk factors for CA-BSI.

Table 4
Multiple Logistic Regression Analysis Assessing the Risk Factors Associated with Catheter-Associated Bloodstream Infection

Discussion

This study is the first multicenter study in Korea which showed that an active multidisciplinary intervention could reduce the incidence of catheter-related bloodstream infection. The maximal reduction of CA-BSI rates in our study occurred during the 3 months of intervention and was sustained after an active intervention. However, the effect declined shortly after finishing intervention. The result of infection rate surveillance in the post-intervention period showed slight increase of CA-BSI rate. Three months of intervention might be too short to achieve a maximum decrease of infection rate. According to a multicenter intervention by Warren et al., it took approximately 7-12 months to change practice pattern of nurses and physicians, thereby getting a maximum reduction of infection rate [15]. In another multicenter study including more than 100 ICUs which had low infection rate (2.7 per 1000 catheter-days) before the intervention [16], the median rate of infection reached 0 within 3 months after implementation of intervention to decrease CA-BSIs, and continued throughout 15 months of follow-up. In the baseline period of this study, the CA-BSI rates of each hospital were higher than 75 percentile of CA-BSI rates from medical or surgical ICUs in the National Healthcare Safety Network of the USA (4.2 or 4.4 case per 1,000 catheter days) [1], but lower than mean rate obtained in 8 developing countries (12.5 case per 1,000 catheter days) [17], It is, therefore, warranted to compare the efficacies of 3-month intervention and that of longer-period intervention in order to determine whether longer period of intervention is needed to achieve a maximal reduction of infection and sustain this reduction in hospitals with high CA-BSI rate.

Industrialized countries such as the USA and UK have established standards for institutional surveillance and control of healthcare-associated infection [1, 22]. Most studies related to healthcare-associated infection have been conducted in developed countries and demonstrated the efficacy of surveillance and its significant contribution to minimizing morbidity, mortality, and medical cost [2, 3, 8-10, 12, 13, 15, 16, 23]. On the other hand, only a few studies on healthcare-associated infection using standardized definitions and intervention are available in developing countries, especially in Asia [24, 25]. As suggested earlier, studies from developing countries showed higher rates of device-associated infection and this could be due to the lack of guidlines mandating healthcare-associated infection control programs, variable hand hygiene standards, scarce funds and resource - especially lower nurse-to-patient staffing ratios in ICUs - for infection control, and limited use of outdated technology for prevention [17]. A higher baseline infection rate together with these limitations seemed to work against maintaining sustained improvement after the active intervention in the current study. Surveillance of healthcare-associated infections appears to be truly the first step toward reducing the risk of infection in vulnerable hospitalized patients. Our experiences, however, indicate that continued efforts of active intervention are needed to sustain the reduced infection rate after the surveillance.

In this study, 3 university hospitals harboring similar number of ICU beds were enrolled, but the infection rate and outcome of intervention were different in each hospital. The reason can be partly because of several differences in catheter-practices and clinical characteristics of the patients in each hospital (data not shown). For example, subclavian vein insertion rate was practiced in 28.6%, 67% or 76% in each hospital patients, respectively (P<0.001), and the places where catheter was inserted were significantly different (ICU, ER or OR): 33%, 23% or 30% vs. 79%, 7% or 8% vs. 28%, 34% or 29% in each hospital, respectively (P<0.001). Mean age of the patients, severity score of baseline diseases, and duration of admission were also different. Therefore, to decrease the CA-BSI, careful observation and understanding the problems in catheter-practice in each institution are necessary.

It is noted in this study that infection by gram-negative bacteria was dramatically decreased during and after the intervention. Bacteremia due to these organisms emerges usually from non-catheter-related sources, such as nosocomial urinary tract infection or nosocomial pneumonia. During the intervention period, one-time use of sterile 3-way cap of infusion hub and cleaning of injection port with 70% alcohol before accessing the infusion system were recommended to reduce hub-originated catheter infection in this study. In one report, surveillance hub culture predicted the pathogen of CA-BSI especially when gram-negative organisms were identified [26] and in another report, hub contamination control reduced CA-BSI caused by gram-negative organisms, although statistical significance was not found [27]. Therefore we thought that those interventions might reduce bacteremia due to gram-negative bacteria in this study. When CVC is no longer necessary, immediate removal would also contribute to the reduction of infection.

This study has several limitations. The study design, a preintervention-postintervention comparison, diminished the ability to make a causal relation between the intervention and reduction in CA-BSI rates. However, since randomized controlled assignment of the intervention in an ICU setting was not feasible, several intervention studies adopted pre-postintervention design [15, 16]. Second, CA-BSI rates varied among three hospitals involved, suggesting substantial differences in severity of illness, efficiency of surveillance, and availability of institutional resources for prevention between the hospitals. This variation is likely to have occurred, because bloodstream infections are rare and the presence of small number of cases or outbreaks substantially affects the infection rate. Third, because of the same reason as mentioned above, each center did not show significant reduction in CA-BSI rates both during and after the intervention, in spite of the reduction in overall CA-BSI rate. Last, we included only three medical centers that voluntarily participated in the intervention, thus limiting the ability to generalize the findings.

Both in the developing and the developed countries, catheter-associated bloodstream infections are a huge threat to the safety of patients. This study demonstrated that a multi-strategy approach to reduce CA-BSI can be implemented in a diverse setting of medical and surgical units in Korea and can decrease CA-BSI rates during the intervention. Future interventional effort is urgently needed to prolong the effect of intervention which includes diverse strategy for a longer period of time, depending on each center's demand.

Notes

This study was supported by 2007 Antimicrobial Resistance grant from Korean Center for Disease Control & Prevention.

References

    1. Edwards JR, Peterson KD, Andrus ML, Tolson JS, Goulding JS, Dudeck MA, Mincey RB, Pollock DA, Horan TC. NHSN Facilities. National healthcare safety network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007;35:290–301.
    1. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
    1. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–981.
    1. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164–167.
    1. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003;29:471–475.
    1. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027–1030.
    1. Lee SO, Kim S, Lee J, Kim KM, Kim BH, Kim ES, Kim JH, Kim TH, Kim HY, Park SW, Pai H, Uh Y, Lee ES, Jang YS, Chang YJ, Han MJ, Kang JO, Kim MN, Kim MJ, Park ES, Oh HS, Jeong JS, Lee YS, Oh HB, Choi TY. Korean Nosocomial Infections Surveillance System (KONIS). Korean nosocomial infections surveillance system (KONIS) report: Data summary from July through September 2006. Korean J Nosocomial Infect Control 2006;11:113–128.
    1. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864–1868.
    1. Lobo RD, Levin AS, Gomes LM, Cursino R, Park M, Figueiredo VB, Taniguchi L, Polido CG, Costa SF. Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil. Am J Infect Control 2005;33:83–87.
    1. Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ. Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme. J Hosp Infect 1998;40:211–224.
    1. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31:405–409.
    1. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T, Haponik EF. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132:641–648.
    1. Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, Kollef MH. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004;126:1612–1618.
    1. Yoo S, Ha M, Choi D, Pai H. Effectiveness of surveillance of central catheter-related bloodstream infection in an ICU in Korea. Infect Control Hosp Epidemiol 2001;22:433–436.
    1. Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, Tokars JI, Noskin GA, Wong ES, Sepkowitz KA, Herwaldt LA, Perl TM, Solomon SL, Fraser VJ. Prevention Epicenter Program. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 2006;27:662–669.
    1. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.
    1. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H. International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145:582–591.
    1. Yoo JY, Kim EJ, Yun IS, Lee JS, Lee JY, Byun JM, Ha KH, Yoon SW, Yoon SE, Kang JM. Impact of maximal sterile barrier during the insertion of central venous catheters in adults intensive care units. Korean J Nosocomial Infect Control 2007;12:36–41.
    1. Jung YJ, Koh Y, Lim CM, Lee JS, Yu MH, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Hong SB. The central venous catheter-related infection of chlorhexidine-silver sulfadiazine coated catheters in medical ICU. Tuberc Respir Dis 2005;59:389–396.
    1. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 2002;110:e51.
    1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
    1. Barrett SP. Infection control in Britain. J Hosp Infect 2002;50:106–109.
    1. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control 2008;36:S171.
    1. Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, Sahu S, Gopinath R, Rodrigues C, Kapoor P, Jawali V, Chakraborty P, Raj JP, Bindhani D, Ravindra N, Hegde A, Pawar M, Venkatachalam N, Chatterjee S, Trehan N, Singhal T, Damani N. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007;67:168–174.
    1. Chen YY, Wang FD, Liu CY, Chou P. Incidence rate and variable cost of nosocomial infections in different types of intensive care units. Infect Control Hosp Epidemiol 2009;30:39–46.
    1. Sitges-Serra A, Hernández R, Maestro S, Pi-Suñer T, Garcés JM, Segura M. Prevention of catheter sepsis: the hub. Nutrition 1997;13 Suppl 4:30S–35S.
    1. León C, Alvarez-Lerma F, Ruiz-Santana S, González V, de la Torre MV, Sierra R, León M, Rodrigo JJ. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study. Critical Care Medicine 2003;31:1318–1324.

Metrics
Share
Tables

1 / 4

PERMALINK